(19)
(11) EP 2 528 926 A1

(12)

(43) Date of publication:
05.12.2012 Bulletin 2012/49

(21) Application number: 11736580.9

(22) Date of filing: 24.01.2011
(51) International Patent Classification (IPC): 
C07D 519/00(2006.01)
A61K 31/444(2006.01)
A61P 31/14(2006.01)
A61K 31/439(2006.01)
A61K 31/506(2006.01)
(86) International application number:
PCT/CA2011/050041
(87) International publication number:
WO 2011/091532 (04.08.2011 Gazette 2011/31)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 26.04.2010 US 327900 P
28.01.2010 US 299186 P

(71) Applicant: Boehringer Ingelheim International GmbH
55216 Ingelheim am Rhein (DE)

(72) Inventors:
  • KUHN, Cyrille
    Laval, Quebec H7S 2G5 (CA)
  • BHARDWAJ, Punit K .
    Laval, Quebec H7S 2G5 (CA)
  • POUPART, Marc-Andre
    Laval, Quebec H7S 2G5 (CA)

(74) Representative: Simon, Elke Anna Maria et al
Boehringer Ingelheim GmbH Binger Strasse 173
55216 Ingelheim am Rhein
55216 Ingelheim am Rhein (DE)

   


(54) HEPATITIS C INHIBITOR COMPOUNDS